Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 2
2017 pubmed 40 citations

The Mla pathway is critical for Pseudomonas aeruginosa resistance to outer membrane permeabilization and host innate immune clearance.

Munguia. Jason J; LaRock. Doris L DL; Tsunemoto. Hannah H; Olson. Joshua J; Cornax. Ingrid I; Pogliano. Joseph J; Nizet. Victor V

Key Findings

  • The Mla (VacJ) pathway protects P. aeruginosa’s outer membrane from damage.
  • Deleting vacJ makes the bacteria more vulnerable to the human peptide LL‑37 and other stressors like SDS and EDTA.
  • vacJ‑deficient bacteria are cleared faster by human blood, serum, and in a mouse lung infection model, reducing disease severity.

Practical Outcomes

  • Targeting the Mla pathway could be a strategy to boost the body’s innate immune killing of P. aeruginosa, potentially leading to new adjunct therapies. For now, there’s no direct DIY protocol, but the finding highlights a promising drug target for future antimicrobial development.

Summary

The study shows that a bacterial system called the Mla pathway helps Pseudomonas aeruginosa resist the natural antimicrobial peptide LL‑37. When the vacJ gene in this pathway is knocked out, the bacteria become leaky, die more easily from LL‑37, blood, and serum, and cause less severe lung infections in mice. This suggests that blocking the Mla pathway could make the body’s own LL‑37 more effective against this bug.

Abstract

Pseudomonas aeruginosa is an important opportunistic pathogen that has become a serious problem due to increased rates of antibiotic resistance. Due to this along with a dearth in novel antibiotic development, especially against Gram-negative pathogens, new therapeutic strategies are needed to prevent a post-antibiotic era. Here, we describe the importance of the vacJ/Mla pathway in resisting bactericidal actions of the host innate immune response. P. aeruginosa tn5 transposon mutants in genes from the VacJ/Mla pathway showed increased susceptibility to killing by the host cathelicidin antimicrobial peptide, LL-37, when compared to the wild-type parent strain. The P. aeruginosa vacJ <sup>-</sup> mutant demonstrated increased membrane permeability upon damage as well as sensitivity to killing in the presence of the detergent sodium dodecyl sulfate and the divalent cation chelator EDTA. When exposed to human whole blood and serum complement, the vacJ <sup>-</sup> mutant was killed more rapidly when compared to the wild-type parent strain and complemented mutant. Finally, in an in vivo mouse lung infection model, infection with the vacJ <sup>-</sup> mutant resulted in reduced mortality, lower bacterial burden, and reduced lung damage when compared to the wild-type strain. This study highlights the potential in therapeutically targeting the VacJ/Mla pathway in sensitizing P. aeruginosa to killing by the host innate immune response. &#x2022; The Mla pathway regulates outer membrane dynamics in human pathogen Pseudomonas aeruginosa (PA). &#x2022; Disruption of Mla pathway gene vacJ sensitizes PA to host cathelicidin antimicrobial peptide LL-37. &#x2022; Loss of vacJ expression renders PA more sensitive to human whole blood and serum killing. &#x2022; Loss of vacJ expression reduces PA survival and virulence in a murine lung infection model. &#x2022; The Mla pathway merits exploration as a pharmacologic target to sensitize PA to host innate immunity.

Study Information

Provider

pubmed

Year

2017

Date

2017-08-26T00:00:00.000Z

DOI

10.1007/s00109-017-1579-4

Citations

40

References

48